Active surveillance and watchful waiting for low-risk prostate cancer is on the rise, but urologists, practices, and facilities differ greatly in their uptake of these approaches.
Missed appointments and other impediments to continuity of care are among the major challenges urologists report when managing poverty-stricken men with prostate cancer.
Study reveals geographic differences in the use of innovative technological approaches to diagnose and treat prostate cancer.
The COVID-19 pandemic has led to changes in prostate cancer care and research across the United States, but to varying degrees.
Patients with prostate cancer who live in rural areas are less likely than their urban counterparts to receive treatment and make follow-up visits after RP.
Disparities in access to medical care are among the factors thought to contribute to geographic variations in prostate cancer death rates and the treatments patients receive.